119 related articles for article (PubMed ID: 31868059)
1. The therapeutic effects of blocking IGF-R1 on mice model of skin cancer.
Alyoussef A
J Dermatolog Treat; 2021 Nov; 32(7):803-811. PubMed ID: 31868059
[TBL] [Abstract][Full Text] [Related]
2. Evaluating antitumor activity of antiglypican-3 therapy in experimentally induced skin cancer in mice.
Alyoussef A
Arch Dermatol Res; 2021 May; 313(4):263-273. PubMed ID: 32638071
[TBL] [Abstract][Full Text] [Related]
3. Blocking Wnt as a therapeutic target in mice model of skin cancer.
Alyoussef A; Taha M
Arch Dermatol Res; 2019 Oct; 311(8):595-605. PubMed ID: 31165240
[TBL] [Abstract][Full Text] [Related]
4. Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth.
Gable KL; Maddux BA; Penaranda C; Zavodovskaya M; Campbell MJ; Lobo M; Robinson L; Schow S; Kerner JA; Goldfine ID; Youngren JF
Mol Cancer Ther; 2006 Apr; 5(4):1079-86. PubMed ID: 16648580
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
[TBL] [Abstract][Full Text] [Related]
6. Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion.
DiGiovanni J; Bol DK; Wilker E; Beltrán L; Carbajal S; Moats S; Ramirez A; Jorcano J; Kiguchi K
Cancer Res; 2000 Mar; 60(6):1561-70. PubMed ID: 10749124
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of susceptibility to diverse skin tumor promoters by activation of the insulin-like growth factor-1 receptor in the epidermis of transgenic mice.
Wilker E; Bol D; Kiguchi K; Rupp T; Beltrán L; DiGiovanni J
Mol Carcinog; 1999 Jun; 25(2):122-31. PubMed ID: 10365914
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of sulforaphane in mice model of skin cancer via blocking sulfatase-2.
Alyoussef A; Taha M
Exp Dermatol; 2019 Jan; 28(1):28-34. PubMed ID: 30315662
[TBL] [Abstract][Full Text] [Related]
9. Chemopreventive effects of curcumin on chemically induced mouse skin carcinogenesis in BK5.insulin-like growth factor-1 transgenic mice.
Kim H; Park J; Tak KH; Bu SY; Kim E
In Vitro Cell Dev Biol Anim; 2014 Oct; 50(9):883-92. PubMed ID: 25027711
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
[TBL] [Abstract][Full Text] [Related]
11. The insulin-like growth factor 1 receptor is expressed by epithelial cells with proliferative potential in human epidermis and skin appendages: correlation of increased expression with epidermal hyperplasia.
Hodak E; Gottlieb AB; Anzilotti M; Krueger JG
J Invest Dermatol; 1996 Mar; 106(3):564-70. PubMed ID: 8648195
[TBL] [Abstract][Full Text] [Related]
12. PQ401, an IGF-1R inhibitor, induces apoptosis and inhibits growth, proliferation and migration of glioma cells.
Zhou X; Zhao X; Li X; Ping G; Pei S; Chen M; Wang Z; Zhou W; Jin B
J Chemother; 2016; 28(1):44-9. PubMed ID: 25971682
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45.
Li H; Adachi Y; Yamamoto H; Min Y; Ohashi H; Ii M; Arimura Y; Endo T; Lee CT; Carbone DP; Imai K; Shinomura Y
Cancer; 2011 Jul; 117(14):3135-47. PubMed ID: 21264842
[TBL] [Abstract][Full Text] [Related]
14. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
15. Role of PI3K/Akt signaling in insulin-like growth factor-1 (IGF-1) skin tumor promotion.
Wilker E; Lu J; Rho O; Carbajal S; Beltrán L; DiGiovanni J
Mol Carcinog; 2005 Oct; 44(2):137-45. PubMed ID: 16086373
[TBL] [Abstract][Full Text] [Related]
16. The effects of type 1 IGF receptor inhibition in a mouse model of diabetic kidney disease.
Troib A; Landau D; Youngren JF; Kachko L; Rabkin R; Segev Y
Growth Horm IGF Res; 2011 Oct; 21(5):285-91. PubMed ID: 21865067
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma.
Zaghloul RA; El-Shishtawy MM; El Galil KH; Ebrahim MA; Metwaly AA; Al-Gayyar MM
Eur J Pharmacol; 2015 Jan; 746():353-62. PubMed ID: 25449037
[TBL] [Abstract][Full Text] [Related]
19. Targeting for insulin-like growth factor-I receptor with short hairpin RNA for human digestive/gastrointestinal cancers.
Wang Y; Adachi Y; Imsumran A; Yamamoto H; Piao W; Li H; Ii M; Arimura Y; Park MY; Kim D; Lee CT; Carbone DP; Imai K; Shinomura Y
J Gastroenterol; 2010 Feb; 45(2):159-70. PubMed ID: 19902140
[TBL] [Abstract][Full Text] [Related]
20. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
